Algorae Pharmaceuticals Stock (OTC: LVCLF)

Latest news for Algorae Pharmaceuticals (OTC:LVCLF) Stock

Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for under met medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. The products of the company comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The company is conceptualized to be a potential treatment for dementia, including Alzheimer's disease, NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.

ALGORAE PHARMACETICLS LTD by ALGORAE PHARMACEUTICALS LTD.

Algorae Pharmaceuticals Ltd

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals Ltd. announces the successful launch of its AI-driven platfo...

Algorae Pharmaceuticals Unveils AI-Driven Drug Discovery Platform

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals has successfully launched its AI platform, AlgoraeOS, which ...

Algorae Pharmaceuticals Launches AI Platform and Advances Drug Trials

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals Limited is making strides in drug development with the launc...

Algorae Pharmaceuticals Boosts Drug Development with AI

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals Limited has announced the successful outcome of its Annual G...

Algorae Pharmaceuticals Secures Shareholder Support at AGM

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals Limited has announced a proposal to issue 40 million perform...

Algorae Pharmaceuticals Plans Major Securities Issuance

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals has ceased its American Depositary Share program on the OTCQ...

Algorae Pharmaceuticals Streamlines Operations with OTCQB Exit

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals Limited has announced a proposed issuance of 23,890,665 opti...

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals has expanded its therapeutic pipeline with 24 new AI-generat...

Algorae Pharmaceuticals Expands Pipeline with AI-Driven Targets

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals has appointed Dr. Sarah Siggins to its Scientific Advisory B...

Algorae Pharmaceuticals Strengthens Board with Industry Expert

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals has announced promising preclinical results for its drug can...

Comments

Algorae Pharmaceuticals

News

Latest news for Algorae Pharmaceuticals (OTC:LVCLF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga